CPG-01-201: An Adaptive Clinical Platform Trial to Evaluate the Safety and Efficacy of COM701 as Monotherapy or Combination Ther

Skip to Content

JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

There is no panel matching the key "Alert---Site-Wide"

Back to Results

CPG-01-201: Early Phase Clinical Trial to Evaluate COM701 in PSOC

CPG-01-201: An Adaptive Clinical Platform Trial to Evaluate the Safety and Efficacy of COM701 as Monotherapy or Combination Therapy as Maintenance Therapy in Participants with Relapsed Platinum Sensitive Ovarian Cancer (PSOC)

Objective

Clinical Trial Details

Clinical Trial Categories

Gynecologic Cancer

Contact

Gynecology Breast Coordinators at 605-322-7536
or gyn.breastresearch@avera.org

Location

Avera Cancer Institute — Sioux Falls
1000 E 23rd St
Suite 340
Sioux Falls, SD 57105
Main: 605-322-3000